Articles

1. Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research

   • Jeremy Basset‑Sagarminaga
   • Tineke van de Weijer
   • Vera Schrauwen‑Hinderling

   Correction 23 February 2024 Pages: 958 - 958

2. Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study

   • Jimmy Célind
   • Maria Bygdell
   • Jenny M. Kindblom

   Article Open access 22 February 2024 Pages: 874 - 884

   

3. Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

   • Pedro Cardoso
   • Katie G. Young
   • on behalf of the MASTERMIND consortium

   Article Open access 22 February 2024 Pages: 822 - 836

   

4. Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?

   • Sophie Béliard
   • Florian Mourre
   • René Valéro

   Review Open access 20 February 2024 Pages: 974 - 984

   

5. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment

   • Richard I. G. Holt
   • Clive S. Cockram
   • Andrea O. Y. Luk

   Review Open access 20 February 2024

   

6. Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits

   • Jianxin Zhen
   • Yuqin Gu
   • Siyang Liu

   Article Open access 19 February 2024 Pages: 703 - 713

   

7. An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study

   • Roderick C. Slieker
   • Magnus Münch
   • Joline W. J. Beulens

   Article Open access 19 February 2024 Pages: 885 - 894

   

8. Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial

   • Heikki Hyöty
   • Susanna Kääriäinen
   • Miguel Sanjuan

   Article Open access 19 February 2024 Pages: 811 - 821

   

9. A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life

   • Natascia Vedovato
   • Maria V. Salguero
   • Frances M. Ashcroft

   Article Open access 17 February 2024 Pages: 940 - 951

   

10. Metabolomic and genetic architecture of gestational diabetes subtypes

    • Kristen Lee
    • Alan Kuang
    • William L. Lowe Jr

    Article 17 February 2024 Pages: 895 - 907

    

11. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis

    • Milena Jancev
    • Tessa A. C. M. Vissers
    • Thomas T. van Sloten

    Article Open access 16 February 2024 Pages: 798 - 810

    

12. Up Front

    Up Front 16 February 2024 Pages: 571 - 572

    

13. The insulin resistant brain: impact on whole-body metabolism and body fat distribution

    • Martin Heni

    Review Open access 16 February 2024

    

14. Feasibility of prevention of type 2 diabetes in low- and middle-income countries

    • Andre P. Kengne
    • Ambady Ramachandran

    Review Open access 15 February 2024 Pages: 763 - 772

    

15. Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data

    • Pedro F. Teixeira
    • Tadej Battelino
    • Gun Forsander

    For Debate Open access 14 February 2024 Pages: 985 - 994

    

16. Keeping pace: the primary cilium as the conducting baton of the islet

    • Olof Idevall-Hagren
    • Ceren Incedal Nilsson
    • Gonzalo Sanchez

    Review Open access 14 February 2024 Pages: 773 - 782

    

17. Correction to: Dose–response effects on HbA_1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

    • Matthias Blüher
    • Julio Rosenstock
    • Anita M. Hennige

    Correction Open access 13 February 2024 Pages: 758 - 758

    

18. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes

    • Mengqi Guo
    • Han Guo
    • Shufa Li

    Article 13 February 2024 Pages: 623 - 640

    

19. Referees 2023

    LIST OF REFEREES 13 February 2024 Pages: 573 - 573

20. Harnessing the power of proteomics in precision diabetes medicine

    • Nigel Kurgan
    • Jeppe Kjærgaard Larsen
    • Atul S. Deshmukh

    Review 12 February 2024 Pages: 783 - 797

    

21. Epidemiology of heart failure in diabetes: a disease in disguise

    • Anna G. Hoek
    • Elisa Dal Canto
    • Joline W. J. Beulens

    Review Open access 09 February 2024 Pages: 574 - 601

    

22. Surveillance of the liver in type 2 diabetes: important but unfeasible?

    • Sami Qadri
    • Hannele Yki-Järvinen

    Review Open access 09 February 2024 Pages: 961 - 973

    

23. Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial

    • Zatollah Asemi
    • Maryam Karamali
    • Ahmad Esmaillzadeh

    Editorial Expression of Concern 30 January 2024 Pages: 759 - 760

24. Morning exercise as fasted-state activity. Reply to Chacko E [letter]

    • Caiwei Tian
    • Chirag J. Patel

    Letter 25 January 2024 Pages: 757 - 757

25. QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts

    • Rodrigue Garcia
    • Linda C. Schröder
    • on behalf of the SURDIAGENE and the Mini-Finland study groups

    Article 24 January 2024 Pages: 641 - 649

    

26. Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study

    • John Samuelsson
    • Rebecka Bertilsson
    • Karin Åkesson

    Article Open access 22 January 2024 Pages: 679 - 689

    

27. Up Front

    Up Front 22 January 2024 Pages: 405 - 406

    

28. Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study

    • Peter J. Raubenheimer
    • Joanna Skelton
    • Naomi S. Levitt

    Article Open access 19 January 2024 Pages: 494 - 505

    

29. Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns

    • Mingwei Shao
    • Duo Chen
    • Guijun Qin

    Article 18 January 2024 Pages: 738 - 754

    

30. Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium

    • Margaretha M. Visser
    • Astrid Van Muylder
    • Nick Verhaeghe

    Article 18 January 2024 Pages: 650 - 662

    

31. Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study

    • Edward W. Gregg
    • Haiying Chen
    • for the Look AHEAD Research Group

    Article Open access 18 January 2024 Pages: 459 - 469

    

32. Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes

    • Karoliina Tuomela
    • Megan K. Levings

    Review 18 January 2024 Pages: 611 - 622

    

33. Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α

    • Beibei Liu
    • Di Xie
    • Yingqun Huang

    Article Open access 13 January 2024 Pages: 724 - 737

    

34. Morning exercise as fasted-state activity

    • Elsamma Chacko

    Letter 12 January 2024 Pages: 755 - 756

35. Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children

    • Sara Bruzzaniti
    • Erica Piemonte
    • Mario Galgani

    Article Open access 12 January 2024 Pages: 714 - 723

    

36. Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes

    • Sandra Hummel
    • Sarah Rosenberger
    • for the GPPAD and POInT Study Group

    Article Open access 12 January 2024 Pages: 670 - 678

    

37. Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia

    • Hamzah Alzubaidi
    • Vitor H. Oliveira
    • Jonathan E. Shaw

    Short Communication Open access 12 January 2024 Pages: 663 - 669

    

38. Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia

    • Judit Castillo‑Armengol
    • Flavia Marzetta
    • Bernard Thorens

    Correction Open access 11 January 2024 Pages: 403 - 403

39. NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function

    • Sharon Baumel-Alterzon
    • Liora S. Katz
    • Donald K. Scott

    Article 11 January 2024 Pages: 547 - 560

    

40. Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study

    • Nikki C. C. Werkman
    • Gema García-Sáez
    • Coen D. A. Stehouwer

    Article Open access 11 January 2024 Pages: 690 - 702

    

41. Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

    • Roshan Dhanapalaratnam
    • Tushar Issar
    • Arun V. Krishnan

    Short Communication 08 January 2024 Pages: 561 - 566

    

42. Remission of type 2 diabetes: always more questions, but enough answers for action

    • Amy Rothberg
    • Michael Lean
    • Blandine Laferrère

    Review Open access 08 January 2024 Pages: 602 - 610

    

43. Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018

    • Nolwenn Regnault
    • Elodie Lebreton
    • Emmanuel Cosson

    Article Open access 05 January 2024 Pages: 516 - 527

    

44. Type 2 diabetes and succinate: unmasking an age-old molecule

    • Sonia Fernández-Veledo
    • Anna Marsal-Beltran
    • Joan Vendrell

    Review Open access 05 January 2024 Pages: 430 - 442

    

45. Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]

    • Nicholas J. Thomas
    • Angus G. Jones

    Letter 04 January 2024 Pages: 569 - 570

46. Comments on the notion of false positivity in measurements of autoantibodies

    • Valdemar Grill
    • Elin Sørgjerd
    • Sofia Carlsson

    Letter 04 January 2024 Pages: 567 - 568

47. Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

    • Rabeeyah Ahmed
    • Russell J. de Souza
    • Sonia S. Anand

    Article Open access 04 January 2024 Pages: 443 - 458

    

48. The impact of taxing sugar-sweetened beverages on diabetes: a critical review

    • José L. Peñalvo

    Review 04 January 2024 Pages: 420 - 429

    

49. Up Front

    Up Front 23 December 2023 Pages: 221 - 222

    

50. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

    • Nikhil R. Gandasi
    • Rui Gao
    • Patrik Rorsman

    Extended Article Open access 21 December 2023 Pages: 528 - 546